Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost‐effectiveness analysis

Faculty Opinions recommendation of Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.740520099.793587462 ◽

2021 ◽

Author(s):

Yoshio Yamaoka ◽

Seiji Shiota

Keyword(s):

Gastric Cancer ◽

Helicobacter Pylori ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Health Impacts ◽

Helicobacter Pylori Eradication ◽

Effectiveness Analysis ◽

Eradication Strategy

Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model

Digestive Diseases and Sciences ◽

10.1007/s10620-019-05910-1 ◽

2019 ◽

Vol 65 (6) ◽

pp. 1679-1688 ◽

Cited By ~ 4

Author(s):

Yan Han ◽

Tianlian Yan ◽

Han Ma ◽

Xin Yao ◽

Chao Lu ◽

...

Keyword(s):

Gastric Cancer ◽

Helicobacter Pylori ◽

Cost Effectiveness ◽

Markov Model ◽

Eradication Therapy ◽

Cost Effectiveness Analysis ◽

Helicobacter Pylori Eradication ◽

Effectiveness Analysis ◽

Helicobacter Pylori Eradication Therapy

Cost‑effectiveness Analysis of Helicobacter pylori Eradication Therapy in First-Degree Relatives of Patients with Gastric Cancer

Patient Preference and Adherence ◽

10.2147/ppa.s286860 ◽

2021 ◽

Vol Volume 15 ◽

pp. 77-85

Author(s):

Hanrui Zheng ◽

Qian Xie ◽

Mei Zhan ◽

Chaohui Jin ◽

Qiu Li

Keyword(s):

Gastric Cancer ◽

Helicobacter Pylori ◽

Cost Effectiveness ◽

Eradication Therapy ◽

Cost Effectiveness Analysis ◽

Helicobacter Pylori Eradication ◽

First Degree Relatives ◽

Effectiveness Analysis ◽

Helicobacter Pylori Eradication Therapy

Cost-effectiveness analysis of universal noninvasive testing for post-treatment confirmation of Helicobacter pylori eradication and the impact of patient adherence

Patient Preference and Adherence ◽

10.2147/ppa.s102760 ◽

2016 ◽

pp. 1025

Author(s):

Tao Wang ◽

Susan Boklage ◽

Allen Mangel ◽

Varun Ramamohan ◽

Deirdre Mladsi ◽

...

Keyword(s):

Helicobacter Pylori ◽

Cost Effectiveness ◽

Patient Adherence ◽

Cost Effectiveness Analysis ◽

Post Treatment ◽

Noninvasive Testing ◽

Helicobacter Pylori Eradication ◽

Effectiveness Analysis ◽

The Impact

Helicobacter Pylori Related Gastric Cancer Screening and Cost-Effectiveness Analysis: A Hospital-Based Cross-Sectional Study (SIGES)

Nutrition and Cancer ◽

10.1080/01635581.2021.2022168 ◽

2022 ◽

pp. 1-10

Author(s):

Wen Xiang ◽

Rui Wang ◽

Dan Bai ◽

Tian-Hang Yu ◽

Xin-Zu Chen ◽

...

Keyword(s):

Gastric Cancer ◽

Helicobacter Pylori ◽

Cost Effectiveness ◽

Cancer Screening ◽

Cross Sectional Study ◽

Cost Effectiveness Analysis ◽

Sectional Study ◽

Cross Sectional ◽

Effectiveness Analysis ◽

Gastric Cancer Screening

Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients a cost-effectiveness analysis

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cpp44149 ◽

2006 ◽

Vol 44 (04) ◽

pp. 149-153 ◽

Cited By ~ 6

Author(s):

J.H.S. You ◽

W. Lau ◽

I.Y.C. Lee ◽

M. Yung ◽

J.Y.L. Ching ◽

...

Keyword(s):

Helicobacter Pylori ◽

Cost Effectiveness ◽

Drug Therapy ◽

Cost Effectiveness Analysis ◽

Chinese Patients ◽

Helicobacter Pylori Eradication ◽

Inflammatory Drug ◽

Effectiveness Analysis ◽

Anti Inflammatory

Cost effectiveness analysis of population-based serology screening and 13C-Urea breath test for Helicobacter pylori to prevent gastric cancer: A markov model

World Journal of Gastroenterology ◽

10.3748/wjg.14.3021 ◽

2008 ◽

Vol 14 (19) ◽

pp. 3021 ◽

Cited By ~ 20

Author(s):

Feng Xie

Keyword(s):

Gastric Cancer ◽

Helicobacter Pylori ◽

Cost Effectiveness ◽

Markov Model ◽

Breath Test ◽

Population Based ◽

Cost Effectiveness Analysis ◽

Urea Breath Test ◽

Effectiveness Analysis ◽

13C Urea Breath Test

Faculty Opinions recommendation of Cost-effectiveness analysis and effectiveness of pharmacist-managed outpatient clinics in Helicobacter pylori eradication therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735399673.793558723 ◽

2019 ◽

Author(s):

Yoshio Yamaoka ◽

Seiji Shiota

Keyword(s):

Helicobacter Pylori ◽

Cost Effectiveness ◽

Eradication Therapy ◽

Cost Effectiveness Analysis ◽

Outpatient Clinics ◽

Helicobacter Pylori Eradication ◽

Effectiveness Analysis ◽

Helicobacter Pylori Eradication Therapy

Cost‐effectiveness analysis and effectiveness of pharmacist‐managed outpatient clinics in Helicobacter pylori eradication therapy

International Journal of Clinical Practice ◽

10.1111/ijcp.13349 ◽

2019 ◽

Vol 73 (6) ◽

pp. e13349 ◽

Cited By ~ 1

Author(s):

Takayuki Seko ◽

Tomoya Tachi ◽

Hiroo Hatakeyama ◽

Yoshihiro Noguchi ◽

Hitomi Teramachi

Keyword(s):

Helicobacter Pylori ◽

Cost Effectiveness ◽

Eradication Therapy ◽

Cost Effectiveness Analysis ◽

Outpatient Clinics ◽

Helicobacter Pylori Eradication ◽

Effectiveness Analysis ◽

Helicobacter Pylori Eradication Therapy

PGI6: COST-EFFECTIVENESS ANALYSIS OF HELICOBACTER PYLORI ERADICATION TRIPLE THERAPY VERSUS CONVENTIONAL THERAPY FOR GASTRIC AND DUODENAL ULCERS IN JAPAN

Value in Health ◽

10.1046/j.1524-4733.2001.40202-147.x ◽

2001 ◽

Vol 4 (2) ◽

pp. 123

Author(s):

S Ikeda ◽

T Tamamuro ◽

M Asaka

Keyword(s):

Helicobacter Pylori ◽

Cost Effectiveness ◽

Triple Therapy ◽

Conventional Therapy ◽

Cost Effectiveness Analysis ◽

Duodenal Ulcers ◽

Helicobacter Pylori Eradication ◽

Effectiveness Analysis

Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost‐effectiveness analysis

Faculty Opinions recommendation of Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.

Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model

Cost‑effectiveness Analysis of Helicobacter pylori Eradication Therapy in First-Degree Relatives of Patients with Gastric Cancer

Cost-effectiveness analysis of universal noninvasive testing for post-treatment confirmation of Helicobacter pylori eradication and the impact of patient adherence

Helicobacter Pylori Related Gastric Cancer Screening and Cost-Effectiveness Analysis: A Hospital-Based Cross-Sectional Study (SIGES)

Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients  a cost-effectiveness analysis

Cost effectiveness analysis of population-based serology screening and 13C-Urea breath test for Helicobacter pylori to prevent gastric cancer: A markov model

Faculty Opinions recommendation of Cost-effectiveness analysis and effectiveness of pharmacist-managed outpatient clinics in Helicobacter pylori eradication therapy.

Cost‐effectiveness analysis and effectiveness of pharmacist‐managed outpatient clinics in Helicobacter pylori eradication therapy

PGI6: COST-EFFECTIVENESS ANALYSIS OF HELICOBACTER PYLORI ERADICATION TRIPLE THERAPY VERSUS CONVENTIONAL THERAPY FOR GASTRIC AND DUODENAL ULCERS IN JAPAN

Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients a cost-effectiveness analysis